MOA-9 Drop-In Replacement For Brij 35 | Technical Specs
MOA-9 Drop-in Replacement vs Brij 35 30% Solution Specifications
Technical procurement for laboratory surfactants requires precise alignment of physicochemical parameters to ensure method validity. The Emulsifier MOA Series, specifically MOA-9 (CAS: 3055-93-4), functions as a robust drop-in replacement for standard 30% nonionic detergent solutions historically used in protein methods and HPLC applications. When evaluating equivalence, critical metrics include molecular weight distribution, critical micelle concentration (CMC), and solution stability. Standard incumbent 30% solutions typically exhibit a molecular weight around 1225 g/mol with a CMC of 0.09 mM. MOA-9, classified as a Fatty Alcohol Polyoxyethylene Ether, is engineered to match these performance benchmarks while offering improved supply chain consistency.
The following table delineates the key specification parameters required for validation during raw material qualification. Procurement teams should verify batch-specific data against these thresholds to ensure compatibility with existing protocols.
| Parameter | Standard 30% Solution Benchmark | MOA-9 Target Specification |
|---|---|---|
| Visual Appearance | Clear, colorless viscous liquid | Clear, colorless viscous liquid |
| Concentration (w/w) | 27.0% to 30.0% | 29.0% to 31.0% |
| Detergent Class | Non-ionic | Non-ionic Ethoxylated Fatty Alcohol |
| Critical Micelle Concentration | 0.09 mM (0.011% w/v) | 0.08 to 0.10 mM |
| Cloud Point | >100°C | >95°C |
| Micelle Molecular Weight | Approx. 49,000 g | Comparable Aggregation |
| Aggregation Number | 40 | 38 to 42 |
Adherence to these specifications ensures that the Polyoxyethylene Fatty Alcohol Ether structure maintains the necessary hydrophilic-lipophilic balance (HLB) for stabilizing protein interfaces without denaturation. Deviations in concentration outside the 27-30% range can alter ionic strength in buffers, potentially affecting electrophoretic mobility or chromatographic retention times.
Validating MOA-9 Performance in HPLC and Protein Methods
Integration of a new surfactant into High-Performance Liquid Chromatography (HPLC) or protein purification workflows demands rigorous validation of baseline stability and UV cutoff characteristics. Nonionic surfactants are frequently employed to prevent non-specific binding in cell lysis buffers or as mobile phase additives in micellar electrokinetic chromatography. The primary risk during substitution is the introduction of UV-absorbing impurities that elevate baseline noise below 220 nm.
MOA-9 undergoes purification processes designed to minimize low-molecular-weight ethoxylates and free fatty alcohols, which are common sources of UV interference. In protein methods, the surfactant must solubilize membrane proteins while preserving enzymatic activity. The aggregation number of approximately 40 ensures that micelles form rapidly above the CMC, providing consistent solubilization power across different batch lots. Validation protocols should include a blank run using the surfactant solution in the mobile phase to confirm absorbance stability over a 60-minute gradient. Furthermore, protein recovery rates should be compared against historical data obtained with incumbent materials to verify that the MOA Emulsifier does not interfere with downstream mass spectrometry or immunoassay detection.
Improving Handling Efficiency Over High Viscosity Brij 35 Solutions
Operational efficiency in high-throughput laboratories is often constrained by the physical handling properties of reagents. Standard 30% nonionic detergent solutions are characterized by high viscosity at ambient temperatures, frequently requiring warming to 70°C to facilitate accurate pipetting or automated dispensing. This thermal dependency introduces variability in concentration if the solution cools during transfer and increases energy consumption for heating blocks.
MOA-9 formulations are optimized for improved rheological profiles. While maintaining the necessary surfactant concentration, the Fatty Alcohol Polyoxyethylene Ether composition offers lower viscosity at room temperature compared to traditional 30% solutions. This reduction in viscosity enhances flow rates in automated liquid handling systems, reducing cycle times for buffer preparation. Additionally, lower viscosity minimizes the risk of air entrapment during mixing, which can lead to inconsistent dosing in sensitive protein assays. Procurement managers should note that eliminating the requirement for pre-heating to 70°C reduces the risk of thermal degradation for temperature-sensitive additives mixed concurrently with the surfactant.
Step-by-Step Protocol for MOA-9 Integration in Formulations
Transitioning to MOA-9 within existing formulations requires a systematic approach to verify compatibility and performance. The following protocol outlines the technical steps for qualification without disrupting ongoing R&D operations.
- Initial Solubility Check: Prepare a 1% working solution in ultrapure water. Verify clarity and absence of particulate matter after 24 hours at room temperature.
- Buffer Compatibility: Mix the surfactant with standard lysis buffers (e.g., PBS, Tris-HCl) at final working concentrations. Monitor for precipitation or phase separation over 48 hours.
- Performance Benchmarking: Run parallel assays using the incumbent surfactant and MOA-9. Compare protein yield, enzyme activity, and HPLC baseline noise.
- Scale-Up Verification: Once bench-top validation is successful, proceed to pilot-scale mixing to ensure homogeneity in larger volumes.
For chemists managing multiple surfactant substitutions across different ethoxylation levels, additional technical data is available. Refer to the Emulsifier MOA Series Brij 30 Equivalent Moa-3 Formulation Guide for comprehensive details on lower ethoxylate variants and their specific application niches in textile and industrial processing. This ensures that the entire MOA portfolio is utilized correctly according to HLB requirements.
Ensuring Supply Chain Stability and Compliance for R&D Procurement
Reliable access to high-purity chemical reagents is critical for maintaining continuity in long-term research projects. Supply chain disruptions for specialized surfactants can halt production lines or invalidate multi-year studies. NINGBO INNO PHARMCHEM CO.,LTD. maintains robust manufacturing capabilities for the Emulsifier MOA Series, ensuring consistent availability of CAS 3055-93-4. Procurement strategies should prioritize suppliers who provide comprehensive documentation beyond standard safety data sheets.
Quality assurance for R&D materials must focus on analytical data rather than regulatory claims. Each batch should be accompanied by a Certificate of Analysis (COA) detailing GC-MS purity profiles, water content, and pH values. It is essential to verify that the material meets internal specifications for heavy metals and residual solvents, particularly if the surfactant is used in processes leading to pharmaceutical intermediates. For detailed product specifications and to verify current stock levels for the Emulsifier MOA Series Fatty Alcohol Polyoxyethylene Ether, review the technical documentation provided directly by the manufacturer. Consistent quality control ensures that every shipment matches the performance characteristics validated during the initial qualification phase.
Transitioning to a verified alternative secures the supply chain against market volatility while maintaining technical performance standards required for sensitive analytical and protein methods.
To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.